Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Tests an online support program for people with inflammatory bowel disease

Tests online education and support for adults with Crohn disease or ulcerative colitis.

Plain-language title generated from the registry record
Registry title: Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients

Key facts

Where
Hangzhou, Huzhou, Shanghai, and Shaoxing, ChinaSee the 4 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT05719766, who can take part

Where in China

  • Center of Inflammatory Bowel Disease, Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHangzhou, ChinaNo longer taking part
  • Department of Gastroenterology, Huzhou Central HospitalHuzhou, ChinaNo longer taking part
  • Department of Gastroenterology, Ruijin HospitalShanghai, ChinaNo longer taking part
  • Department of Gastroenterology, Shaoxing Central HospitalShaoxing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Second Affiliated Hospital, Zhejiang University, School of Medicine
Trial code
NCT05719766
Record updated
21 February 2023
Original description
This study aims to prospectively explore the effect of incentive-integrated E-IBD (electronic inflammatory bowel disease) chronic disease management model on the improvement of IBD quality of life, and provide a more effective chronic disease management model for improving the quality of life and social participation of IBD patients.The investigators firstly identify the IBD patients in need of empowerment disease activities through the questionnaire .Then, the investigators feedback the patients' education content according to their needs found.Based on the social support network of patient organization and the medical support network of tertiary medical institutions, the investigators complete the empowerment process of IBD patients' self-management initiative and self-management ability, through the internet. Finally ,the investigators evaluate the quality of life(QoL), social participation,disease self-management level via questionnaire . The primary outcome is the improvement of QoL score after three months' intervention.Read full original descriptionShow less

Perspective Study on How Can the Incentive Integrated E-IBD Chronic Disease Management Model Improve the Quality of Life in IBD Patients

This study aims to prospectively explore the effect of incentive-integrated E-IBD (electronic inflammatory bowel disease) chronic disease management model on the improvement of IBD quality of life, and provide a more effective chronic disease management model for improving the quality of life and social participation of IBD patients.The investigators firstly identify the IBD patients in need of empowerment disease activities through the questionnaire .Then, the investigators feedback the patients' education content according to their needs found.Based on the social support network of patient organization and the medical support network of tertiary medical institutions, the investigators complete the empowerment process of IBD patients' self-management initiative and self-management ability, through the internet. Finally ,the investigators evaluate the quality of life(QoL), social participation,disease self-management level via questionnaire . The primary outcome is the improvement of QoL score after three months' intervention.

Inclusion: 1.Clinically diagnosed IBD patients,according to the criteria of the Inflammatory Bowel Group of the Gastroenterology Branch of the Chinese Medical Association in 2018; 2.Aged 18 to 75 years old; 3.Understand and comply with the requirements of the program and sign informed consent; 4.Identified as need intervention according to the patient identification questionnaire screening; 5.Patients with the ability to complete all course training and/or follow-up work; 6.Enrolled at least one year ahead of end of this study(for garantee of enough folllow-up time).

Exclusion: 4.Patients with other malignancies or life-threatening complications;; 1.Unable or unwilling to sign the consent form, or unable to follow the research procedure; 2.Patients who have had a stoma or ileorectal anastomosis (partial scales are not available); 3.Patients who do not complete training on time or do not complete follow-up assessments in their entirety; 5.Pregnancy or lactation;; 6.Patients whose remaining follow-up time less than one year before the end of this study.

ClinicalTrials.gov NCT05719766